TRU-SENTIMENT · DeltaNeutral
CRBP Trading Analysis - 09/15/2026 12:31 PM — TRU-SENTIMENT
Options chain · Stock chart · Baseline chart
CRBP (Corbus Pharmaceuticals Holdings, Inc.) at $6.54. True Sentiment Bearish, delta 40-60 call 1% / put 99%, call $11,175 vs put $1,803,740. RSI 9.7.
- Symbol
- CRBP
- Price
- $6.54
- Article bias (separate from True Sentiment)
- bearish
- Conviction
- medium
- Published
- 2026-09-15 12:31:00 ET
- Author
- DeltaNeutral staff
TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)
True Sentiment Analysis (Delta 40-60 Options):The overall options flow sentiment is bearish, with a call dollar volume of $11,175 and a put dollar volume of $1,803,740. The put-call ratio suggests a strong bearish conviction.
Key Statistics: CRBP
📈 Analysis
News Headlines & Context:
Recent news highlights positive trial data and analyst ratings for CRBP. HC Wainwright reiterated a $435 target for CRBP with a Buy rating. The company featured positive topline data from its Phase 1b CANYON-1 trial of CRB-913 for obesity, showing weight loss comparable to leading oral GLP-1 therapies with fewer side effects.
X/Twitter Sentiment (live xAI x_search, cited only):
| User | Post | Sentiment | Time | Link |
|---|---|---|---|---|
| Explainbiotech | Good point. CRB-701 deserves a place in the valuation discussion too. Most of today’s attention has been on obesity, but the oncology program also matters when assessing what $CRBP is worth. #Biotech | Bullish | Mon, 14 Sep 2026 23:42:37 GMT | https://x.com/Explainbiotech/status/2099645023037882678 |
| Temple_of_Boom | RECAP of <#1535370187023319081> alerts: ... $CRBP 25% ... | Bullish | Mon, 14 Sep 2026 23:30:17 GMT | https://x.com/Temple_of_Boom/status/2099641916933476614 |
| MarcJacksonLA | $CRBP -HC Wainwright reiterates Corbus Pharmaceuticals 435 target Buy | Bullish | Mon, 14 Sep 2026 21:06:31 GMT | https://x.com/MarcJacksonLA/status/2099605738587046162 |
| CorbusPharma | @FT featured positive topline data from our Phase 1b CANYON-1 trial of CRB-913 for #obesity, highlighting weight loss comparable to leading oral GLP-1 therapies with markedly less nausea, vomiting & constipation in a 200+ patient trial. ... $CRBP | Bullish | Mon, 14 Sep 2026 20:49:57 GMT | https://x.com/CorbusPharma/status/2099601570321089004 |
Recent posts highlight positive $CRBP trial data, analyst buy ratings, and stock gains amid some valuation caution.
Current Market Position:
CRBP is currently trading at $6.55. Recent price action shows a significant drop from $8.08 on Sep 14 to $6.33 on Sep 15, before recovering slightly.
Technical Analysis:
Technical Indicators
The stock is currently below its SMA 5, 20, and 50-day lines, indicating a bearish trend. RSI is at 9.66, suggesting the stock is oversold. MACD is at -0.49, indicating a bearish signal.
True Sentiment Analysis (Delta 40-60 Options):
The overall options flow sentiment is bearish, with a call dollar volume of $11,175 and a put dollar volume of $1,803,740. The put-call ratio suggests a strong bearish conviction.
Key Price Levels:
25-Day Price Forecast:
CRBP is projected for $5.50 to $7.20 in 25 days, based on current technical trends, momentum, and indicators.
Defined Risk Strategy Recommendations:
Based on the price forecast, recommended strategies include:
- Bull Call Spread: Buy 7.5 call, sell 10 call
- Bear Put Spread: Buy 5 put, sell 2.5 put
- Iron Condor: Sell 7.5 call, buy 10 call, sell 5 put, buy 2.5 put
Risk Factors:
Technical warning signs include oversold RSI and bearish MACD. Sentiment divergences from price action and high volatility are also concerns.
Summary & Conviction Level:
Overall bias: Bearish. Conviction level: Medium. Trade idea: Consider bearish strategies given the bearish sentiment and technical indicators.
View CRBP Options Chain